FindTrial
Sign In

UGN-101 instillations

DRUG2 trials

Sponsors

UroGen Pharma Ltd.

Conditions

CarcinomaCarcinoma, Transitional CellTransitional Cell Cancer of the Renal Pelvis and UreterTransitional Cell CarcinomaTransitional Cell Carcinoma of Renal Pelvis

Phase 3

The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
CompletedNCT02793128
UroGen Pharma Ltd.Carcinoma, Transitional Cell, Transitional Cell Carcinoma of Renal Pelvis
Start: 2017-04-04End: 2020-03-05Updated: 2020-12-22
Efficacy and Safety of UGN-101 in Recurrent Patients
WithdrawnNCT04006691
UroGen Pharma Ltd.Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter, Transitional Cell Carcinoma
Start: 2019-10-01End: 2020-03-31Updated: 2020-05-07

Related Papers

Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal Gel
The Journal of Urology2024-11-191 citations
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
2021-12-1746 citations
MP48-18 FEMALE PATIENTS WITH LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA: PRIMARY CHEMOABLATION AND DURABILITY OF RESPONSE IN A SUBGROUP ANALYSIS FROM THE OLYMPUS TRIAL
The Journal of Urology2021-08-041 citations
LBA02-10 LONG-TERM RECURRENCE FREE SURVIVAL FOLLOWING UGN-101 TREATMENT FOR LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA
The Journal of Urology2021-08-04
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.
2021-03-0710 citations
UGN-101 (mitomycin gel): a novel treatment for low-grade upper tract urothelial carcinoma.
2020-07-0312 citations
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
2020-04-2997 citations
PD18-07 PRIMARY CHEMOABLATION FOR THE TREATMENT OF LOW GRADE UPPER TRACT UROTHELIAL CARCINOMA: THE OLYMPUS TRIAL
The Journal of Urology2020-04-01
Thermo Reversible Hydrogel Based Delivery of Mitomycin C (UGN-101) for Treatment of Upper Tract Urothelial Carcinoma (UTUC)
Bladder Cancer2018-10-2211 citations
LBA25 NON-SURGICAL MANAGEMENT OF LOW GRADE UPPER TRACT UROTHELIAL CANCER: AN INTERIM ANALYSIS OF THE INTERNATIONAL MULTICENTER OLYMPUS TRIAL (NCT02793128)
The Journal of Urology2018-04-013 citations